(Q43083741)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Physiological modulation of circulating FGF21: relevance of free fatty acids and insulin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Andreas Pfeiffer

series ordinal

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

11

Joachim Spranger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

10

Matthias Möhlig

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

2

Thomas Bobbert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

Knut Mai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

4

Anke Assmann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

5

Sabine Meinus

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

7

Janin Andres

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Christian Groth

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jessica Kraatz

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

27 April 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Endocrinology and Metabolism

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

299

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

E126-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Postprandial triglyceride response in visceral obesity in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

FGF-21 as a novel metabolic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Metabolic and hormonal changes during the refeeding period of prolonged fasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Plasma FGF-21 levels in type 2 diabetic patients with ketosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Free fatty acids link metabolism and regulation of the insulin-sensitizing fibroblast growth factor-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00020.2010

10.1152/AJPENDO.00020.2010

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20424140%20AND%20SRC:MED&resulttype=core&format=json

release_frpgi6szcjanndcn2t37waxxqy

1 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/frpgi6szcjanndcn2t37waxxqy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference